These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2375908)

  • 1. HLA class I expression on erythrocytes and platelets from patients with systemic lupus erythematosus, rheumatoid arthritis and from normal subjects.
    Botto M; So AK; Giles CM; Mason PD; Walport MJ
    Br J Haematol; 1990 May; 75(1):106-11. PubMed ID: 2375908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
    Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
    Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MHC class I determinants on erythrocytes of SLE patients.
    Giles CM; Walport MJ; David J; Darke C
    Clin Exp Immunol; 1987 Aug; 69(2):368-74. PubMed ID: 3308228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus.
    Tsuchiya N; Shiota M; Yamaguchi A; Ito K
    Arthritis Rheum; 1996 May; 39(5):792-6. PubMed ID: 8639176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features.
    Brand CA; Rowley MJ; Tait BD; Muirden KD; Whittingham SF
    Ann Rheum Dis; 1992 Feb; 51(2):173-6. PubMed ID: 1550399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid HLA class I expression in 300 patients with haematological, renal and rheumatological disorders.
    Ranasinghe WA; Giles CM; Pusey CD; Hows J; Ritter MA; Walport MJ
    Vox Sang; 1990; 59(1):55-9. PubMed ID: 2396373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
    Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
    Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies.
    Giles CM; Botto M; King MJ
    Transfusion; 1990 Feb; 30(2):126-32. PubMed ID: 1689515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.
    Adamashvili I; Wolf R; Aultman D; Milford EL; Jaffe S; Hall V; Pressly T; Minagar A; Kelley R
    Rheumatol Int; 2003 Nov; 23(6):294-300. PubMed ID: 12879264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus, rheumatoid arthritis and HLA phenotypes in Jamaicans.
    Smikle MF; Barton EN; DeCeulaer K; Williams WN; James OB
    West Indian Med J; 1995 Mar; 44(1):11-3. PubMed ID: 7793105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I (Bg) antigens on red cells of SLE patients: a serological study with polyclonal and monoclonal antibodies.
    Giles CM; Darke C; Rowe GP; Botto M
    Vox Sang; 1989; 56(4):254-61. PubMed ID: 2763504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.
    Ferraccioli G; Savi M
    J Rheumatol; 1988 Jan; 15(1):51-3. PubMed ID: 3258384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCĪ“/ERK Signaling Pathway.
    He XJ; Ding Y; Xiang W; Dang XQ
    Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
    Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
    J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
    Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
    Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.